Filing Flows › TransMedics Group (TMDX) › Gross margin
TransMedics Group (TMDX) gross margin by quarter
TransMedics Group's gross margin was 58.5% in Q3 2026 (third quarter 2026), -1.1 pts from Q2 2026. Over the last 7 quarters it ranged from 58.1% (Q4 2025) to 61.5% (Q1 2025).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 58.5% | -1.1 pts | -0.4 pts |
| Q2 2026 | 59.6% | +1.4 pts | -1.8 pts |
| Q1 2026 | 58.2% | +0.1 pts | -3.3 pts |
| Q4 2025 | 58.1% | -0.7 pts | — |
| Q3 2025 | 58.8% | -2.6 pts | — |
| Q2 2025 | 61.4% | -0.1 pts | — |
| Q1 2025 | 61.5% | — | — |
Q3 2026 at a glance
TransMedics Group, Q3 2026: revenue $203M (+41% year over year), operating margin 13.9%, net earnings $17.1M, operating cash flow $36.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is TransMedics Group's gross margin?
TransMedics Group's gross margin was 58.5% in Q3 2026 (third quarter 2026), -1.1 pts from Q2 2026.
How has TransMedics Group's gross margin changed?
Over the last 7 quarters it ranged from 58.1% (Q4 2025) to 61.5% (Q1 2025).